- Home
- YMAB vs BNY Comparison
YMAB vs BNY Comparison
Compare YMAB & BNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- BNY
- Stock Information
- Founded
- YMAB 2015
- BNY 2001
- Country
- YMAB United States
- BNY United States
- Employees
- YMAB N/A
- BNY N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- BNY Trusts Except Educational Religious and Charitable
- Sector
- YMAB Health Care
- BNY Finance
- Exchange
- YMAB Nasdaq
- BNY Nasdaq
- Market Cap
- YMAB 218.4M
- BNY 249.4M
- IPO Year
- YMAB 2018
- BNY N/A
- Fundamental
- Price
- YMAB $4.69
- BNY $9.78
- Analyst Decision
- YMAB Buy
- BNY
- Analyst Count
- YMAB 11
- BNY 0
- Target Price
- YMAB $18.73
- BNY N/A
- AVG Volume (30 Days)
- YMAB 318.1K
- BNY 52.7K
- Earning Date
- YMAB 05-06-2025
- BNY 01-01-0001
- Dividend Yield
- YMAB N/A
- BNY 3.93%
- EPS Growth
- YMAB N/A
- BNY N/A
- EPS
- YMAB N/A
- BNY N/A
- Revenue
- YMAB $87,685,000.00
- BNY N/A
- Revenue This Year
- YMAB N/A
- BNY N/A
- Revenue Next Year
- YMAB $21.10
- BNY N/A
- P/E Ratio
- YMAB N/A
- BNY N/A
- Revenue Growth
- YMAB 3.38
- BNY N/A
- 52 Week Low
- YMAB $3.86
- BNY $8.60
- 52 Week High
- YMAB $17.78
- BNY $10.80
- Technical
- Relative Strength Index (RSI)
- YMAB 47.75
- BNY 35.46
- Support Level
- YMAB $4.46
- BNY $9.63
- Resistance Level
- YMAB $5.44
- BNY $9.80
- Average True Range (ATR)
- YMAB 0.45
- BNY 0.17
- MACD
- YMAB 0.07
- BNY -0.02
- Stochastic Oscillator
- YMAB 52.53
- BNY 27.38
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About BNY BlackRock New York Municipal Income Trust
Blackrock NY Municipal Income Tr has an investment objective to provide current income exempt from regular U.S. federal income tax and New York State and New York City personal income taxes. The Trust seeks to achieve its investment objective by investing primarily in municipal bonds exempt from U.S. federal income taxes and New York State and New York City personal income taxes.